Personalized Medicine with Pharmacogenomic Testing: Your Path to Precision Healthcare

GenePoweRx

Pharmacogenomics (PGX)

Utilizes whole exome test customized to meet the specific requirements of doctors. We convert the complex genomic information into clinical insights to help prescribe the right medications.

Applying deep tech analytics on Pharmacogenomic databases available across the world, gives you access to molecular information on your patients, which will help you manage your patient’s medications precisely.

Technical details

Sample required- 2ml EDTA blood sample with consent form
Technique used- Next gen sequencing using Illumina NovaSeq sequencer
In house developed Bioinformatics algorithms for data analysis
Final report generation using global Databases
TAT of 3 weeks

Official Analytics partner

(Developed the first FDA approved Cancer Companion Diagnostic Test)

The world’s oldest and largest private cancer center, and GenePower(by K&H), partnered into collaboration that will utilize MSK’s clinical and research insights into gene mutations associated with solid tumors along with K&H proprietary database to provide accurate recommendations for Indian population.

Highlights

A directional test for tumor profiling enabling oncologists to predict response/ resistance to targeted and immuno-therapies for cancer patients over the traditional molecular testing.

Over 5600 genomic alterations covered-

We report substitutions, insertions, deletions, CNV, select rearrangements as well as genomic signatures including microsatellite instability and tumor mutation burden

We are the only company in Genomics space

lead by physicians in India.

Simplified reports

without ambiguous reporting is possible because we know exactly what a treating physician is looking for in the report

Open Discussion channel

between Oncologist, Pathologist and genomic specialist physician will lead to best treatment choices for the patient.

What is Pharmacogenomics Test?

A comprehensive test that recommends the right medicine at the right dose for individual patients based on genetic profiling, phenotype analysis and lifestyle conditions. It helps the physicians to prescribe the best drugs for all chronic conditions, drugs to avoid at any cost and the best antibiotic to be recommended when needed.

Pharmacogenomics test helps to identify how an individual’s genetic make-up affects the drug response, this enables the physician to identify the right dose for the patient and provides data on the safety and efficacy levels of the drug used for the patient.

Who is the GenepoweRx Pharmacogenomics Test meant for?

Any patient who is currently battling a disease condition and is taking multiple medications may benefit from a pharmacogenomics test, which a doctor might advise. Patients who are having untoward side effects from medication include those who are prone to common allergies, have chronic illnesses, or experience recurrent illnesses.

When should the Pharmacogenomics Test be done?

A patient who has just received a diagnosis of a disease condition, such as metabolic disorders or persistent allergies, and who wants to gain an insight into drug response recommendations before beginning therapy, can undergo the pharmacogenomics test.

Why should you consider GenepoweRx Pharmacogenomics Test?

Pharmacogenomics helps doctors predict and analyse the risks involved with drug regimen prescription to patients. The GenepoweRx test is a whole-exome test customised to meet the specific requirement of the patients.

The Genetic information of the patient is comprehensive, but with GenepoweRx this complex information is converted into usable insights aiding the decision making of the doctor.

Founding member of Pharmacogenomics Research Network
Member of Clinical Pharmacogenetics Implementation Consortium

How is the test done?

Step 1 : Sample required- 2ml EDTA blood sample with consent form
Step 2 : Technique used- Next gen sequencing using Illumina NovaSeq sequencer
Step 3 : In house developed Bioinformatics algorithms for data analysis
Step 4 : Final report generation using Databases in association with MSK Cancer hospital TAT of 3 weeks